Pancreatic Cancer Research

ResearcherThe University of QueenslandActive in the last 2 years

John David Hooper

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1054-8486; OpenAlex author ID A5001191708. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Indocyanine Green-Labeled Antibodies Cotargeting CDCP1 and Mesothelin for Fluorescence-Guided Imaging of Pancreatic Cancer. Last author DOI 10.1021/acs.molpharmaceut.5c01452↗
  2. Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarcinoma: Implications for Early Diagnosis o… Last author DOI 10.1053/j.gastro.2024.06.033↗
  3. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Last author DOI 10.7150/thno.43589↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Cavallucci · 2 shared papers, 2024–2026 · strength 0.48
  2. William T. McGahan · 2 shared papers, 2024–2026 · strength 0.48
  3. Johnny X. Huang · 1 shared paper, 2026 · strength 0.32
  4. Marina Pajic · 2 shared papers, 2020–2024 · strength 0.25
  5. Thomas Kryza · 2 shared papers, 2020–2024 · strength 0.25
  6. Jaswinder Singh Samra · 1 shared paper, 2024 · strength 0.17
  7. Anthony James Gill · 1 shared paper, 2024 · strength 0.17
  8. Ashleigh Parkin · 1 shared paper, 2020 · strength 0.08
  9. Andrew P. Barbour · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.